Search

Your search keyword '"Kwekkeboom, Jaap"' showing total 143 results

Search Constraints

Start Over You searched for: Author "Kwekkeboom, Jaap" Remove constraint Author: "Kwekkeboom, Jaap" Database Unpaywall Remove constraint Database: Unpaywall
143 results on '"Kwekkeboom, Jaap"'

Search Results

1. Intestinal Bacteremia After Liver Transplantation Is a Risk Factor for Recurrence of Primary Sclerosing Cholangitis

2. GITR Ligation Improves Anti-PD1-Mediated Restoration of Human MMR-Proficient Colorectal Carcinoma Tumor-Derived T Cells

3. 883 MCLA-145, an anti CD137×PD-L1 bispecific antibody, induces T cell activation and proliferation in ex vivo models of hepatocellular carcinoma

4. 1181 Therapeutic vaccines consisting of cancer germline antigen-based synthetic long peptides are immunogenic in human hepatocellular carcinoma patients

5. Systemic T-cell and humoral responses against cancer testis antigens in hepatocellular carcinoma patients

7. Modelling immune cytotoxicity for cholangiocarcinoma with tumour-derived organoids and effector T cells

8. Current Tolerance-Associated Peripheral Blood Gene Expression Profiles After Liver Transplantation Are Influenced by Immunosuppressive Drugs and Prior Cytomegalovirus Infection

10. An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity

12. Activated CD4 + T Cells and Highly Differentiated Alloreactive CD4 + T Cells Distinguish Operationally Tolerant Liver Transplantation Recipients

14. Expression of Cancer Testis Antigens in Tumor-Adjacent Normal Liver Is Associated with Post-Resection Recurrence of Hepatocellular Carcinoma

17. Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance

18. TIGIT and PD1 Co-blockade Restores ex vivo Functions of Human Tumor-Infiltrating CD8+ T Cells in Hepatocellular Carcinoma

20. 588 Targeting GITR enhances human tumour-infiltrating T cell functionality in mismatch repair proficient primary colorectal carcinoma and liver metastases

21. The biological process of lysine‐tRNA charging is therapeutically targetable in liver cancer

23. FcγRIIB engagement drives agonistic activity of Fc-engineered αOX40 antibody to stimulate human tumor-infiltrating T cells

24. Modelling liver tumor organoids and cancer-associated fibroblasts interaction reveals the robust effects of stromal niche in cancer nurturing and treatment resistance

25. Identification of a panel of safe immunogenic antigens for therapeutic vaccination strategies in hepatocellular carcinoma

26. TIGIT and PD1 dual checkpoint blockade restores functionality of tumor-infiltrating T cells in hepatocellular carcinoma

27. Expression of Cancer testis Antigens in Tumor-adjacent Normal Liver Predicts Post-resection Recurrence of Hepatocellular Carcinoma

28. Enrichment of the tumour immune microenvironment in patients with desmoplastic colorectal liver metastasis

29. LGR5 marks targetable tumor-initiating cells in mouse liver cancer

30. HHLA2 is expressed in pancreatic and ampullary cancers and increased expression is associated with better post-surgical prognosis

31. Observed differences in the tumour microenvironment provide a potential explanation for the superior survival of patients with desmoplastic colorectal liver metastasis

32. Mitochondrial Fusion Via OPA1 and MFN1 Supports Liver Tumor Cell Metabolism and Growth

34. Reduction of immunosuppressive tumor microenvironment in cholangiocarcinoma by ex vivo targeting immune checkpoint molecules

35. Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levels

36. Suppression of Hepatocellular Carcinoma by Mycophenolic Acid in Experimental Models and in Patients

38. GITR ligation enhances functionality of tumor‐infiltrating T cells in hepatocellular carcinoma

39. Dichotomal functions of phosphorylated and unphosphorylated STAT1 in hepatocellular carcinoma

40. Action and clinical significance of CCAAT/enhancer-binding protein delta in hepatocellular carcinoma

41. Modeling liver cancer and therapy responsiveness using organoids derived from primary mouse liver tumors

42. Prognostic value of intra-tumoral CD8+ /FoxP3+ lymphocyte ratio in patients with resected colorectal cancer liver metastasis

43. Blockade of LAG3 enhances responses of tumor-infiltrating T cells in mismatch repair-proficient liver metastases of colorectal cancer

45. Donor-specific anti-HLA antibodies are not associated with nonanastomotic biliary strictures but both are independent risk factors for graft loss after liver transplantation

46. Addendum to “MicroRNA profiles in graft preservation solution are predictive of ischemic-type biliary lesions after liver transplantation” [J Hepatol 2013;59:1231–1238]

48. Dynamics of Proliferative and Quiescent Stem Cells in Liver Homeostasis and Injury

49. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas

50. Cross-Tissue Transcriptomic Analysis of Human Secondary Lymphoid Organ-Residing ILC3s Reveals a Quiescent State in the Absence of Inflammation

Catalog

Books, media, physical & digital resources